the ifpma asian regional conference addresses the growing need to create a culture of innovation for pharmaceuticals and biotechnology in asia by harnessing the national and regional expertise of key global and regional players from governments, research and business.

• intellectual property as a development tool,
• the prerequisites for promoting sustainable r&d in pharmaceuticals and biotechnology,
• the importance of the enforcement of iprs in promoting innovation,
• the role of civil society and patient groups in mobilising support for cutting-edge innovation,
• how to improve pricing and reimbursement policies,
• regional r&d initiatives for tropical diseases,
• the critical role of intellectual property in vaccine development,
• of the importance of data exclusivity for innovation,
• the sustainable use of genetic resources, and
• how to move from a culture of copying to a culture of value-added innovation in pharmaceuticals and biotechnology.

conference participants will be exposed to ground-breaking insights into strategies to innovate, manage, promote and protect pioneering products in a sustainable and practical manner which is compatible with their own business culture and operating environment.

held in singapore, a multicultural crossroad for international shipping and air routes, with its own flourishing chemicals, biomedical and pharmaceutical industries, ifpmas asian conference will seek to further stimulate discussions on the creative forces of innovation in the region. the ifpma looks forward to welcoming internationally-renowned speakers and participants to this, its first asian regional conference. the conference is open to representatives from ifpma member companies, member associations, government officials, and invited members of civil society and other guests. please contact mr. guilherme cintra of the ifpma secretariat (click here to open an e-mail) for more information.